Femasys (FEMY) Cash from Investing Activities (2020 - 2026)
Femasys (FEMY) reported Cash from Investing Activities of -$79138.0 for Q1 2026, up 18.08% on a YoY basis from -$67020.2 in Q1 2025, and up 59.77% quarter-over-quarter from -$196715.0 in Q4 2025.
Femasys (FEMY) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Femasys has reported Cash from Investing Activities for 7 years, with the latest figure at -$79138.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 18.08% year-over-year to -$79138.0; the trailing twelve-month figure through Mar 2026 stood at -$612631.0 (up 28.28% YoY), and the FY2025 full-year result was -$630098.0, up 25.68% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$79138.0, up from -$196715.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$8901.0 in Q1 2023, with the low at -$440028.0 in Q3 2024.
- Historically, Cash from Investing Activities has averaged -$124023.1 across 5 years, with a median of -$96605.0 in 2025.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 92.61% — and 2024, when it plunged 1519.6%.
- Femasys' Cash from Investing Activities stood at -$93877.0 in 2022, then soared by 52.17% to -$44899.0 in 2023, then slumped by 146.36% to -$110613.0 in 2024, then slumped by 77.84% to -$196715.0 in 2025, then jumped by 59.77% to -$79138.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$79138.0 (Q1 2026), -$196715.0 (Q4 2025), and -$239816.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | -79,138.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -79,138.00 |
| Mar 31, 2026 | -79,138.00 |
| Dec 31, 2025 | -196,715.00 |
| Dec 31, 2025 | -196,715.00 |
| Sep 30, 2025 | -239,816.00 |
| Sep 30, 2025 | -239,816.00 |
| Jun 30, 2025 | -96,962.00 |
| Jun 30, 2025 | -96,962.00 |
| Mar 31, 2025 | -96,605.00 |
| Mar 31, 2025 | -96,605.00 |
| Dec 31, 2024 | -110,613.00 |
| Dec 31, 2024 | -110,613.00 |
| Sep 30, 2024 | -440,028.00 |
| Sep 30, 2024 | -440,028.00 |
| Jun 30, 2024 | -206,963.00 |
| Jun 30, 2024 | -206,963.00 |
| Mar 31, 2024 | -90,160.00 |
| Mar 31, 2024 | -90,160.00 |
| Dec 31, 2023 | -44,899.00 |
| Dec 31, 2023 | -44,899.00 |